These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1703522)

  • 1. Inhibitory effects of acyclic retinoid (polyprenoic acid) and its hydroxy derivative on cell growth and on secretion of alpha-fetoprotein in human hepatoma-derived cell line (PLC/PRF/5).
    Fukutomi Y; Omori M; Muto Y; Ninomiya M; Okuno M; Moriwaki H
    Jpn J Cancer Res; 1990 Dec; 81(12):1281-5. PubMed ID: 1703522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
    Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
    Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of polyprenoic acid (E5166) on production and secretion of alpha-fetoprotein and on cell kinetics in human hepatoma cells.
    Sasaki K; Kawasaki S; Okita K; Murakami T; Takemoto T; Takahashi M
    Jpn J Cancer Res; 1986 Mar; 77(3):264-9. PubMed ID: 2422145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells.
    Obora A; Shiratori Y; Okuno M; Adachi S; Takano Y; Matsushima-Nishiwaki R; Yasuda I; Yamada Y; Akita K; Sano T; Shimada J; Kojima S; Okano Y; Friedman SL; Moriwaki H
    Hepatology; 2002 Nov; 36(5):1115-24. PubMed ID: 12395321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines.
    Yamada Y; Shidoji Y; Fukutomi Y; Ishikawa T; Kaneko T; Nakagama H; Imawari M; Moriwaki H; Muto Y
    Mol Carcinog; 1994 Jul; 10(3):151-8. PubMed ID: 7519016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase.
    Noda K; Miyoshi E; Kitada T; Nakahara S; Gao CX; Honke K; Shiratori Y; Moriwaki H; Sasaki Y; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Tumour Biol; 2002; 23(4):202-11. PubMed ID: 12499776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of acyclic retinoid (polyprenoic acid) on the secretion of alpha-fetoprotein in CCl4-treated rats.
    Okuno M; Muto Y; Kato M; Ninomiya M; Moriwaki H; Noma A; Tagaya O; Nozaki Y; Suzuki Y
    J Nutr Sci Vitaminol (Tokyo); 1990 Oct; 36(5):437-46. PubMed ID: 1711115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha-difluoromethyl ornithine on alpha-fetoprotein and albumin secretion in human hepatoma cell line, PLC/PRF/5.
    Nakagawa T; Nakao Y; Matsui T; Koizumi T; Watanabe S; Fujita T
    Cancer Lett; 1985 Sep; 28(3):245-51. PubMed ID: 2413987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7.
    Nakamura N; Shidoji Y; Yamada Y; Hatakeyama H; Moriwaki H; Muto Y
    Biochem Biophys Res Commun; 1995 Feb; 207(1):382-8. PubMed ID: 7857292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
    Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
    Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation induction of human promyelocytic leukemia cells by acyclic retinoid (polyprenoic acid).
    Tsurumi H; Tojo A; Takahashi T; Ozawa K; Moriwaki H; Asano S; Muto Y
    Int J Hematol; 1993 Dec; 59(1):9-15. PubMed ID: 8161738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines.
    Yasuda I; Shiratori Y; Adachi S; Obora A; Takemura M; Okuno M; Shidoji Y; Seishima M; Muto Y; Moriwaki H
    J Hepatol; 2002 May; 36(5):660-71. PubMed ID: 11983450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5.
    Nakagawa T; Nakao Y; Matsui T; Koizumi T; Matsuda S; Maeda S; Fujita T
    Br J Cancer; 1985 Mar; 51(3):357-63. PubMed ID: 2578798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation effect of acyclic retinoid on acute promyelocytic leukemia cells.
    Usuki K; Urabe A; Tojo A; Moriwaki H; Tsurumi H; Ikeda Y; Kizaki M; Toyama K; Aizawa M; Inai K; Muto Y; Asano S; Takaku F
    Ann Hematol; 1996 Nov; 73(5):219-24. PubMed ID: 8959939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
    Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
    Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular alpha-fetoprotein interferes with all-trans retinoic acid induced ATG7 expression and autophagy in hepatocellular carcinoma cells.
    Wang S; Feng R; Shi Y; Chen D; Weng H; Ding H; Zhang C
    Sci Rep; 2021 Jan; 11(1):2146. PubMed ID: 33495541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased GABAergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line.
    Zhang M; Gong Y; Assy N; Minuk GY
    J Hepatol; 2000 Jan; 32(1):85-91. PubMed ID: 10673071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group.
    Muto Y; Moriwaki H; Ninomiya M; Adachi S; Saito A; Takasaki KT; Tanaka T; Tsurumi K; Okuno M; Tomita E; Nakamura T; Kojima T
    N Engl J Med; 1996 Jun; 334(24):1561-7. PubMed ID: 8628336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid.
    Kim DG; Lee DY; Cho BH; You KR; Kim MY; Ahn DS
    Hepatology; 1999 Apr; 29(4):1091-8. PubMed ID: 10094952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.